Search Results - "Gilbert, R. E"

Refine Results
  1. 1

    BOARD-INVITED REVIEW: Peptide absorption and utilization: Implications for animal nutrition and health by Gilbert, E.R, Wong, E.A, Webb, K.E. Jr

    Published in Journal of animal science (01-09-2008)
    “…Over the last 50 yr, the study of intestinal peptide transport has rapidly evolved into a field with exciting nutritional and biomedical applications. In this…”
    Get full text
    Journal Article
  2. 2

    Flavonoids influence epigenetic-modifying enzyme activity: structure - function relationships and the therapeutic potential for cancer by Gilbert, E R, Liu, D

    Published in Current medicinal chemistry (01-06-2010)
    “…Epigenetic modifications result in heritable changes in gene expression without changes to the DNA sequence. The most common forms of epigenetic regulation of…”
    Get more information
    Journal Article
  3. 3

    Are SGLT2 Inhibitors Reasonable Antihypertensive Drugs and Renoprotective? by Lovshin, J. A., Gilbert, R. E.

    Published in Current hypertension reports (01-06-2015)
    “…By eliminating glucose in the urine, the sodium-glucose-linked cotransporter-2 (SGLT2) inhibitors act as osmotic diuretics to lower blood pressure in addition…”
    Get full text
    Journal Article
  4. 4

    Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies by GRAS, L., GILBERT, R. E., WALLON, M., PEYRON, F., CORTINA-BORJA, M.

    Published in Epidemiology and infection (01-06-2004)
    “…We followed up a cohort of 446 toxoplasma-infected pregnant women to determine the median and variability of the duration of positive toxoplasma–IgM…”
    Get full text
    Journal Article
  5. 5

    Chickens from lines selected for high and low body weight show differences in fatty acid oxidation efficiency and metabolic flexibility in skeletal muscle and white adipose tissue by Zhang, S, McMillan, R P, Hulver, M W, Siegel, P B, Sumners, L H, Zhang, W, Cline, M A, Gilbert, E R

    Published in International Journal of Obesity (01-10-2014)
    “…Objective: The Virginia lines of chickens have resulted from more than 55 generations of artificial selection for low (LWS) or high (HWS) juvenile body weight…”
    Get full text
    Journal Article
  6. 6

    Performance of screening tests for child physical abuse in accident and emergency departments by Woodman, J, Pitt, M, Wentz, R, Taylor, B, Hodes, D, Gilbert, R

    “…OBJECTIVESTo determine the clinical effectiveness of screening tests for physical abuse in children attending accident and emergency (A&E) departments in the…”
    Get full text
    Journal Article
  7. 7

    Prediction of congenital toxoplasmosis by polymerase chain reaction analysis of amniotic fluid by Thalib, L., Gras, L., Romand, S., Prusa, A., Bessieres, M.‐H., Petersen, E., Gilbert, R.E.

    “…Objective  To determine the accuracy of polymerase chain reaction (PCR) analysis of amniotic fluid for fetal toxoplasmosis according to clinical predictors of…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes by COOPER, M. E, VRANES, D, YOUSSEF, S, STACKER, S. A, COX, A. J, RIZKALLA, B, CASLEY, D. J, BACH, L. A, KELLY, D. J, GILBERT, R. E

    Published in Diabetes (New York, N.Y.) (01-11-1999)
    “…Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. M E Cooper , D Vranes , S Youssef ,…”
    Get full text
    Journal Article
  10. 10

    The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury? by Gilbert, Richard E., Cooper, Mark E.

    Published in Kidney international (01-11-1999)
    “…Although the glomerulus, particularly the mesangium, has been the focus of intense investigation in diabetes, tubulointerstitial injury is also a major feature…”
    Get full text
    Journal Article
  11. 11

    Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes by GILBERT, R. E, KELLY, D. J, COOPER, M. E, COX, A. J, WILKINSON-BERKA, J. L, RUMBLE, J. R, OSICKA, T, PANAGIOTOPOULOS, S, LEE, V, HENDRICH, E. C, JERUMS, G

    Published in Diabetologia (01-11-2000)
    “…Angiotensin converting enzyme (ACE) inhibition has been recently suggested to have retinoprotective actions in diabetic patients but the mechanism of this…”
    Get full text
    Journal Article
  12. 12

    Aliskiren, a novel renin inhibitor, is renoprotective in a model of advanced diabetic nephropathy in rats by Kelly, D. J, Zhang, Y, Moe, G, Naik, G, Gilbert, R. E

    Published in Diabetologia (01-11-2007)
    “…Aims/hypothesis Blockade of the renin-angiotensin system (RAS) with either ACE inhibitors or angiotensin receptor blocker is a key therapeutic strategy in…”
    Get full text
    Journal Article
  13. 13

    Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases by MCLENNAN, S. V, KELLY, D. J, COX, A. J, CAO, Z, LYONS, J. G, YUE, D. K, GILBERT, R. E

    Published in Diabetologia (01-02-2002)
    “…Extracellular matrix accumulation is thought to be involved in the pathogenesis of diabetic nephropathy. Increased matrix synthesis has been well documented…”
    Get full text
    Journal Article
  14. 14

    Functional, structural and molecular aspects of diastolic heart failure in the diabetic (mRen-2)27 rat by CONNELLY, K. A, KELLY, D. J, KRUM, H, GILBERT, R. E, ZHANG, Y, PRIOR, D. L, MARTIN, J, COX, A. J, THAI, K, FENELEY, M. P, TSOPORIS, J, WHITE, K. E

    Published in Cardiovascular research (01-11-2007)
    “…Diabetic cardiomyopathy is an increasingly recognized cause of cardiac failure despite preserved left ventricular systolic function. Given the over-expression…”
    Get full text
    Journal Article
  15. 15

    The renin-angiotensin system and the long-term complications of diabetes: pathophysiological and therapeutic considerations by Gilbert, R. E., Krum, H., Wilkinson-Berka, J., Kelly, D. J.

    Published in Diabetic medicine (01-08-2003)
    “…The relationship between the renin–angiotensin system (RAS) and the progression of diabetic renal disease has been a major focus of investigation over the past…”
    Get full text
    Journal Article
  16. 16

    Load-sensitive measures may overestimate global systolic function in the presence of left ventricular hypertrophy: a comparison with load-insensitive measures by Connelly, K A, Prior, D L, Kelly, D J, Feneley, M P, Krum, H, Gilbert, R E

    “…Transgenic animal models have provided a vital insight into the pathogenesis of cardiovascular disease, but functional cardiac assessment is often limited by…”
    Get more information
    Journal Article
  17. 17

    Treating Ocular Toxoplasmosis - Current Evidence by Stanford, M.R, Gilbert, R.E

    Published in Memórias do Instituto Oswaldo Cruz (01-03-2009)
    “…The current treatment of ocular toxoplasmosis is controversial. The mainstay of treatment has been pyrimethamine and sulphonamides with or without systemic…”
    Get full text
    Journal Article
  18. 18

    Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells by Qi, W., Chen, X., Twigg, S., Polhill, T.S., Gilbert, R.E., Pollock, C.A.

    Published in Kidney international (01-03-2006)
    “…Tranilast (N-[3,4-dimethoxycinnamoyl]anthranilic acid) is a synthetic compound that we have recently reported to inhibit transforming growth factor-β1…”
    Get full text
    Journal Article
  19. 19

    Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy by Fulcher, G. R., Gilbert, R. E., Yue, D. K.

    Published in Internal medicine journal (01-09-2005)
    “…Aim: To compare glycaemic control and symptomatic hypoglycaemia rates with glargine versus neutral protamine Hagedorn (NPH) in poorly controlled type 1…”
    Get full text
    Journal Article
  20. 20

    Accuracy of bacterial DNA testing for central venous catheter-associated bloodstream infection in children with cancer by Millar, M, Zhou, W, Skinner, R, Pizer, B, Hennessy, E, Wilks, M, Gilbert, R E

    “…Central venous catheters (CVCs) are widely used for children with cancer and are a major risk factor for bloodstream infection. Early and specific diagnosis of…”
    Get full text
    Journal Article